Clobetasol shortage update: What patients need to know in 2026

Clobetasol Shortage 2026: Current Status

If you rely on Clobetasol Propionate to manage psoriasis, eczema, or another severe skin condition, you've probably noticed that it's become harder to find. Here's what we know about the Clobetasol supply situation in 2026 — and what you can do about it.

What the FDA Is Saying

The U.S. Food and Drug Administration (FDA) maintains a drug shortage database that tracks medications with known supply problems. As of early 2026, the FDA has listed Clobetasol Propionate Ointment 0.05% with a discontinuation notice, meaning at least one manufacturer has stopped producing it.

This doesn't mean all Clobetasol products are discontinued — it means the pool of available manufacturers has shrunk. Other companies still make Clobetasol in various forms, but fewer manufacturers mean less supply to go around.

Which Formulations Are Affected?

The shortage doesn't affect all Clobetasol products equally. Here's a breakdown based on current reports:

FormulationStatus (Early 2026)NotesOintment 0.05%⚠️ Limited availabilityMost affected due to manufacturer exitCream 0.05%✅ Generally availableMay be harder to find in some regionsFoam 0.05%⚠️ IntermittentFewer manufacturers; higher costGel 0.05%✅ Generally availableGood alternative to ointmentSolution 0.05%✅ AvailablePrimarily for scalp conditionsSpray 0.05%⚠️ VariableRegional availability differencesShampoo 0.05%✅ AvailableFor scalp psoriasisLotion 0.05%✅ Generally availableMultiple manufacturers active

Why Is This Happening?

Several factors are driving the shortage:

• Manufacturer discontinuations: At least one major generic manufacturer has exited the Clobetasol market. When a company discontinues a product, other manufacturers may not be able to scale up production quickly enough to fill the gap.
• Raw material supply issues: The active pharmaceutical ingredients (APIs) used in topical corticosteroids are sourced globally. Supply chain disruptions — from shipping delays to quality control issues at API plants — can cause ripple effects.
• Low profit margins on generics: Clobetasol is an inexpensive generic drug, which means manufacturers operate on thin margins. Rising production costs can push companies to prioritize more profitable products.
• Regulatory requirements: Manufacturing changes require FDA approval, which takes time. If a manufacturer needs to modify its production process, there may be a gap in supply while waiting for regulatory clearance.

When Will the Shortage End?

Unfortunately, there's no firm timeline. Drug shortages can last anywhere from a few weeks to several months — or longer if underlying manufacturing issues aren't resolved. The FDA works with manufacturers to expedite production, but these processes take time.

We'll continue updating this article as new information becomes available. Bookmark this page and check back for the latest status.

What You Can Do Right Now

Here are practical steps to manage the shortage:

1. Check Multiple Pharmacies

Use MedFinder to search for pharmacies that have Clobetasol in stock near you. Don't rely on just one pharmacy — stock levels change daily. Read our detailed guide on how to find Clobetasol in stock.

2. Be Flexible on Formulation

If your usual formulation is unavailable, ask your doctor about switching. The cream and gel tend to have better availability than the ointment and foam right now.

3. Plan Ahead

Don't wait until you're completely out to refill. Request refills at least a week before your current supply runs out. If your insurance allows 90-day supplies, take advantage of that buffer.

4. Know Your Alternatives

If Clobetasol remains unavailable, there are effective alternatives. Read our guide on Clobetasol alternatives to understand your options.

5. Talk to Your Doctor

Your dermatologist or prescriber may have access to information about local availability, samples, or compounding options that aren't widely known. They can also adjust your treatment plan if needed.

The Bigger Picture: Drug Shortages in the U.S.

Clobetasol is far from the only medication facing supply problems. Drug shortages in the United States have been increasing, with hundreds of medications affected at any given time. The causes are systemic — thin profit margins on generics, concentrated manufacturing, complex supply chains, and regulatory hurdles all play a role.

Organizations like the FDA and ASHP (American Society of Health-System Pharmacists) track shortages and work to resolve them, but the problem requires long-term structural solutions.

Stay Informed

For more information about Clobetasol, check out these related articles:

• Why is Clobetasol so hard to find?
• How to save money on Clobetasol
• What is Clobetasol? Uses, dosage, and what you need to know
• Clobetasol side effects: What to expect

And remember — MedFinder can help you check real-time pharmacy stock so you're not left guessing.